Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Regeneron Pharmaceuticals, Inc. REGN

Healthcare  —  Biotechnology
788.04 (7.98) (1.00%) as of 25 Sep
Market cap
$81.3B
P/E
18.8×
S&P 500 Member Revenue Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Regeneron Pharmaceuticals, Inc. (REGN) P/E ratio

As of 25 September 2026, Regeneron Pharmaceuticals, Inc. (REGN) trades at a P/E ratio of 18.8×. Over the past ten years it has ranged from 7.3× (June 2022) to 152× (June 2015); the current reading is higher than 44% of that period. That is above the Biotechnology industry median of 7.9× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 17.9× 2.73%
FY2024 17.4× (28.66%)
FY2023 24.4× 37.38%
FY2022 17.8× 115.25%
FY2021 8.3× (43.98%)
FY2020 14.7× (23.92%)
FY2019 19.4× 17.50%
FY2018 16.5× (51.36%)
FY2017 33.9× (24.87%)
FY2016 45.1× (48.77%)

Quarterly

Period P/E ratio Change
Jun 2026 14.9× (18.10%)
Mar 2026 18.2× 1.49%
Dec 2025 17.9× 38.30%
Sep 2025 12.9× 2.93%
42 more quarters

Against its own ten years

Low 7.3× High 152×
Ten-year median 20.5×
Current reading's percentile 44

P/E ratio against peers

Company P/E ratio
INSM Insmed, Inc. compare n/m
RVMD Revolution Medicines, Inc. compare n/m
MRNA Moderna, Inc. compare n/m
REGN Regeneron Pharmaceuticals, Inc. 18.8×
VRTX Vertex Pharmaceuticals Incorporated compare 30.4×
ARGX argenex SE compare 34.6×
RPRX Royalty Pharma PLC compare 40.1×
ALNY Alnylam Pharmaceuticals, Inc. compare 43.6×
ONC BeOne Medicines Ltd. - Sponsored ADR compare 61.2×
Biotechnology industry median 7.9×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on REGN